GunturuK., Abu-KhalafM., & SaifM. (2010). Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. JOP. Journal of the Pancreas, 11(5), 484-485. https://doi.org/10.6092/1590-8577/3443